BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13118699)

  • 1. [BAL therapy and copper excretion in hepatolenticular syndrome].
    ERDMANN-MULLER GJ; HORNBOSTEL H
    Klin Wochenschr; 1953 Dec; 31(45-46):1102-3. PubMed ID: 13118699
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).
    PALMER JF; DREW AL; CHENOWETH MB
    Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy.
    SCHECHTER MM; JONES CA
    AMA Arch Intern Med; 1953 Apr; 91(4):541-9. PubMed ID: 13039608
    [No Abstract]   [Full Text] [Related]  

  • 4. DIMERCAPROL for hepatolenticular degeneration.
    Lancet; 1952 Jan; 1(6700):199-200. PubMed ID: 14889814
    [No Abstract]   [Full Text] [Related]  

  • 5. [BAL (2, 3-dimercaptopropanol) therapy of hepatolenticular degeneration].
    BOZHINOV S
    Suvr Med (Sofiia); 1955; 6(7):96-100. PubMed ID: 13299060
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dimercaprol (BAL) in hepatolenticular degeneration; report of a case, with clinical and electroencephalographic study.
    STREIFLER M; FELDMAN S
    AMA Arch Neurol Psychiatry; 1953 Jan; 69(1):84-90. PubMed ID: 12996137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of hepatolenticular degeneration treated by BAL].
    DRABKOWSKA AM
    Neurol Neurochir Psychiatr Pol; 1956; 6(5):541-7. PubMed ID: 13407808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemistry of hepatolenticular degeneration; its treatment with BAL].
    BONDUELLE M; HARL JM
    Bull Med; 1953 Jun; 67(12):333-5. PubMed ID: 13082329
    [No Abstract]   [Full Text] [Related]  

  • 9. [On BAL treatment of hepatolenticular degeneration].
    KNUPPEL H
    Med Klin; 1956 Jan; 51(3):107-8. PubMed ID: 13296803
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatolenticular degeneration; follow-up report of a case treated with dimercaprol (BAL), potassium sulfide, and high-protein diet.
    FERRISS GS; BERRY S
    AMA Arch Intern Med; 1957 Apr; 99(4):656-9. PubMed ID: 13410170
    [No Abstract]   [Full Text] [Related]  

  • 13. [BAL therapy of hepatolenticular degeneration].
    CAROIT M
    Sem Hop; 1955 May; 31(28):1625-6. PubMed ID: 14385888
    [No Abstract]   [Full Text] [Related]  

  • 14. Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
    WARNOCK CG; NEILL DW
    J Neurol Neurosurg Psychiatry; 1954 Feb; 17(1):70-4. PubMed ID: 13131080
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatolenticular degeneration; clinical and pathological report of a case treated with BAL.
    RASKIN N; MACKENZIE JM
    J Nerv Ment Dis; 1954; 120(3-4):176-83. PubMed ID: 13233959
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorders of copper and amino acid metabolism in hepato-cerebral degeneration and their treatment with BAL].
    STEGER J; STEGER R
    Dtsch Z Nervenheilkd; 1954; 172(4):321-51. PubMed ID: 14365436
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal copper metabolism and hepatolenticular degeneration.
    DENNY-BROWN D
    Res Publ Assoc Res Nerv Ment Dis; 1953; 32():190-7. PubMed ID: 13134643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influencing of renal iron and copper excretion].
    GISINGER E; PUXKANDL H
    Wien Z Inn Med; 1955; 36(10-11):491-7. PubMed ID: 13312336
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatolenticular Degeneration].
    GILSANZ V; SEGOVIA JM; CASTROMENDOZA HJ; GOYTRE A
    Rev Clin Esp; 1954 Aug; 54(4):212-25. PubMed ID: 13215904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.